相关实验视频

Updated: Jun 27, 2026

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

型肝炎基因型与HCV-RNA,红细胞相关参数和血小板计数的相关性

Jing Zhao^1,2, Yanrong Li³, He Liang¹

¹Dingxi People's Hospital, Dingxi, Gansu Province, China.

|July 15, 2025

概括

型肝炎的基因型与病毒载荷和血细胞计数相关. 监测红细胞和血小板水平有助于评估C型肝炎病毒 (HCV) 复制和指导治疗.

科学领域:

肝病学肝病学是一种肝病学.
血液学血液学血液学
病毒学病毒学

背景情况:

肝炎C病毒 (HCV) 感染会影响各种血液参数.
了解HCV基因型和血液学指标之间的关系对于临床管理至关重要.

研究的目的:

调查C型肝炎基因型与HCV-RNA水平之间的相关性.
评估HCV基因型与红细胞 (RBC) 相关参数和血小板数 (PLT) 之间的关系.
为诊断和治疗C型肝炎提供临床参考.

主要方法:

对168名慢性型肝炎患者进行了型肝炎基因定型.
测量了红细胞参数 (计数,血红蛋白[HGB]),PLT计数,HCV-RNA和抗HCV水平.
进行了统计分析,包括相关性和接收机运行特征 (ROC) 曲线分析.

主要成果:

与非I型的HCV相比,HCV I型基因组在HCV-RNA和抗HCV中显示出显著的差异.
在HCV I型基因组中,红细胞计数和HGB显著下降.
HCV-RNA水平与红细胞计数,HGB和PLT计数有负相关性.
红细胞计数,HGB和PLT计数在通过ROC分析确定HCV复制时具有临床价值.

结论:

肝炎病毒的基因型会影响血液学参数.
红血细胞和黄血细胞计数是监测HCV复制的有价值指标.
基于血细胞指标的个性化治疗计划建议用于C型肝炎患者.

关键词:

血小板计数血小板计数血小板计数血小板计数基因型基因型基因型型肝炎C型肝炎的发生红细胞计数是指红细胞的计数.病毒RNA病毒RNA病毒

更多相关视频

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...